COMP <GO>
OPCH vs MRK // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Option Care Health Inc. (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: OPCH 4
— MRK 9
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: MRK
LAST: $31.83 (-0.06%) • MKT CAP: $4.77B
options-implied-move
7.20%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
options-implied-move
6.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OPCH VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OPCH | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 19.30% | 74.80% | -55.50 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.90% | 20.70% | -8.80 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.3x | 15.3x | 0.00 | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.55% | 3.42% | +1.13 | OPCH | /fcf-yield <GO> |
| Operating Margin | 6.00% | 34.30% | -28.30 | MRK | /operating-margins <GO> |
| Net Profit Margin | 3.70% | 28.10% | -24.40 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 13.00% | 1.30% | +11.70 | OPCH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.81 | 5.19 | -1.38 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 7.20% | 6.60% | +0.60 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 84.3 | 56.9 | +27.40 | OPCH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | 0.92 | +0.18 | OPCH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.3x | 18.4x | +0.90 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.77B | $361.02B | -$356.25B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OPCH REV | MRK REV | OPCH GROSS % | MRK GROSS % | OPCH FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.65B | $65.01B | 19.3% | 74.8% | $217.1M | $12.36B |
| FY 2024 | $5.00B | $64.17B | 20.3% | 76.3% | $287.8M | $18.10B |
| FY 2023 | $4.30B | $60.12B | 44.0% | 44.0% | $177.7M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OPCH // BETA 1.10
MRK // BETA 0.92